Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
A Q&A with iXCells Biotechnologies CEO, Steve Smith
02/25/2026
8 min read
Interview
False
Advertisement
Related Content
Drug Discovery
Future of Pharma
Interviews
Looking Beyond Symptoms in Psychiatric Drug Development
October 15, 2026
8 min read
Advances in translational science are helping researchers better understand psychiatric disease biology, says Tanya Wallace
Development & Clinical
Cell & Gene
Interviews
Musings From the Power List: Jason Bock
October 14, 2026
12 min read
Jason Bock shares his outlook on RNA-targeting therapies, personalized medicine, and the future of drug development
Development & Clinical
Biopharma
Interviews
Find the Achilles’ Heel: Sitting Down With Amy Jensen-Smith
October 12, 2026
8 min read
SOTIO Biotech’s CSO explains why drug developers should test their weakest assumptions early, how she builds innovative teams, and where ADCs could go next
Development & Clinical
Biopharma
Interviews
Musings from The Power List: Andres Sirulnik
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines